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Familial recurrence of discrete
membranous subaortic stenosis
We read with interest the article by Fatimi
and colleagues1 published in a recent issue
of the Journal.
The authors report on 2 siblings af-
fected by discrete membranous subaortic
stenosis (DMSS), who were born to unaf-
fected consanguineous parents. Literature
reports of familial recurrence of DMSS
were reviewed, and conclusions were that
“review of the pedigrees and the informa-
tion provided in the published reports does
not reveal a clear inheritance pattern.”
Nevertheless, we believe that Mende-
lian autosomal recessive inheritance may
be considered as the main mechanism
involved in the cause of concordant re-
currence of DMSS in families on the
basis of several observations. First, at
least 8 families with recurrence of DMSS
in siblings are reported in the litera-
ture,1-5 including 2 sisters with DMSS
born from unaffected consanguineous
parents described by our group in 19932
(Figure 1, a ). Second, parental consan-
guinity was observed in 4 families with
recurrence of DMSS in siblings, includ-
ing ours.1,2,4 Third, the recurrent cardiac
defect is anatomically concordant in af-
fected siblings from pedigrees with hor-
izontal familial recurrence.1-5
Obviously, genetic heterogeneity is im-
plicated in the cause of DMSS, and the
autosomal dominant inheritance with in-
complete penetrance may be hypothesized
in several instances.1 In fact, parent-to-
child transmission or segregation in uncle
and nephew may be explained in this mat-
ter. In our 6-year (1993–1999) investiga-
tion of family history in patients affected
by nonsyndromic DMSS, 3 additional ped-
igrees with familial recurrence of cardiac
defect have been detected (Figure 1, b-d).
Cardiac defect was concordant in 1 family
(Figure 1, b). In addition, a mother with
DMSS had a child with aortic coarctation
and valvar aortic stenosis (Figure 1, c) and
a proband with DMSS had a cousin af-
fected by tetralogy of Fallot (Figure 1, d).
A multifactorial model of inheritance, sug-
gesting that several chromosomal loci
could interact together in association with
environmental factors, may also be in-
volved, particularly in sporadic cases and
in families with recurrence of discordant
cardiac defect.
Although DMSS is usually considered
an “acquired” cardiac defect with delayed
clinical presentation, the possibility of fa-
milial recurrence suggests a genetic sub-
strate at least in some cases.
The genetic basis of DMSS is still un-
known. In the future, molecular studies will
provide an important aid in the interpreta-
tion of familial recurrence of DMSS.
Genetic heterogeneity of DMSS probably
includes the involvement of different
genes. Similarly to that documented in
some families segregating conotruncal
heart defects, some genes may act accord-
ingly to the autosomal recessive mecha-
nism of inheritance,6 whereas others may
follow the autosomal dominant model with
incomplete penetrance.7,8
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Reply to the Editor:
We thank Piacentini and associates for
their interest in our article1 and for their
expert opinion on the topic. We would like
to focus on three things.
The authors have discussed three new
pedigrees of discrete subaortic stenosis
(DSS), only one of which actually has true
familial recurrence of DSS. The other two
have family members affected by other
forms of congenital heart defects, which
may or may not have the same genetic
basis. Their discussion, however, reiterates
our conclusions that no single inheritance
pattern can be pinpointed by reviewing the
currently available evidence. Genetic het-
erogeneity and incomplete penetrance
could also be important players. We agree
with the authors concerning the autosomal
recessive inheritance, and we think that
given the currently available evidence there
is a greater probability of autosomal reces-
sive inheritance being at play in the famil-
ial causation. At the same time, most fam-
ilies with multiple affected members do not
have consanguineous marriages, and this
argues against involvement of recessive al-
leles. Hence no conclusion can be reached.
Second, as seen in acquired cardiovas-
cular diseases, there may be differences in
the relative contributions of the involved
genes toward causing the phenotype in the
various ethnic groups. Therefore, the pool-
ing and comparison of data from different
population subgroups may actually be mis-
leading. However, owing to the scarcity of
familial DSS patients at any one center, we
still recommend a multicenter approach to
get enough sample size for efficient genetic
screening.
Last, it is important to reinforce the fact
that screening of family members of appar-
ently sporadic cases can lead to timely di-
agnosis and better follow-up of familial
cases.
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Bovine jugular vein as aortic
enlargement patch in the Norwood
procedure
To the Editor:
We have read with interest the brief com-
munication by Healy and colleagues,1 in
which they describe a new and innovative
technique, never before published, concern-
ing use of a bovine jugular vein as an aug-
mentation patch in the Norwood procedure.
The original technique described by
Norwood, Lang, and Hansen2 involved the
use of a homograft to enlarge the aorta. The
lack of availability, its high cost, and the risk
of infection induced some surgeons to use
alternative patches. In fact, in 1999 Gargiulo
and associates3 described aortic augmenta-
tion with a bovine pericardial patch.
We were very enthusiastic about the
Healy report in the Journal, both for its
contribution to the research toward new
alternative materials with respect to ho-
mografts in the Norwood procedure and
because this technique is similar to our
recent surgical strategy.
In 23 Norwood cases, we have used a
Contegra patch (Medtronic, Inc, St Paul,
Minn) to enlarge the aorta. Technically, we
remove the jugular vein with the valve in it
and we open the Contegra patch to perform
aortic enlargement. The operative tech-
nique is not more complex than the original
technique with the homograft. Our results
were very fulfilling and were similar to
these described in the literature with the
classic Norwood operation. We prefer to
use this conduit to reduce the risk of viral
transmission and especially to reduce the
risk of immunologic sensitization, as been
described by Meyer and associates.4 Be-
sides these benefits, the cost is lower.
We hope that our positive experience
can bring a little support to the Haley ex-
perience and technique.
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Improved saphenous vein graft
patency for coronary artery bypass
grafting: “No-touch” harvesting or
“dissection without touching”?
To the Editor:
A recent article in the Journal described the
beneficial effect of penicillamine in a widely
established porcine saphenous vein–carotid
artery interposition model.1 This, and previ-
ous porcine vein graft studies use a “no-
touch” technique of preparing saphenous
veins that was described 30 years ago by
Gottlob.2 This technique was developed us-
ing saphenous vein segments obtained from
bypass operations or cadavers and canine
femoral veins. The aim of this preparation of
“dissection without touching” (the term “no-
touch” seems to have crept into the literature)
was to preserve the vein’s endothelium by a
rather unwieldy method in which “the venous
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